In humans, the MEG3 promoter is hypermethylated in islets from human subjects with T2D, suggesting that MEG3 expression is downregulated in T2D, which may contribute to decreased MAFA expression [83,84]. The gene discussed is MEG3; the disease is type 2 diabetes mellitus.